Revolutionary Radiation Treatment Offers Hope for Patients With ...
Oct 25, 2024 · Tufts Medicine brings a next-generation treatment for advanced prostate cancer that offers new hope for patients whose cancer has spread and no longer responds to hormone therapy or docetaxel chemotherapy.
Mathematical modeling leads to a better understanding of prostate cancer
10 hours ago · Prostate cancer is the most common cancer in men. However, the mechanisms of tumor development, particularly the development of aggressive tumors, are still largely unclear in prostate cancer and ...
Xtandi Approved for High-Risk Prostate Cancer - NCI
Jan 5, 2024 · Enzalutamide (Xtandi) can now be used alone or combined with leuprolide to treat some people with prostate cancer who have had a biochemical recurrence.
FDA approves new treatment for advanced prostate cancer
Jul 12, 2023 · In June, the FDA approved a new treatment for the most advanced type of prostate cancer. Patients who have this condition, which is called metastatic castration-resistant prostate cancer (mCRPC), have few therapeutic options, so the approval helps to fill an urgent need.
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate …
Oct 18, 2023 · Patients who have biochemical recurrence after primary therapy for localized prostate cancer with a PSA doubling time of less than 9 months are at high risk for metastasis and death related...
Prostate Cancer News - ScienceDaily
Oct 23, 2024 · Learn the symptoms of prostate cancer. Read current medical research on new treatment options, vaccines, surgery and prevention.
FDA Approves Promising Therapy for Advanced Prostate Cancer: …
Mar 23, 2022 · Prostate cancer treatment took a major step forward today as the U.S. Food and Drug Administration approved a new therapy that zeros in on cancer cells to destroy them. The treatment, called 177 Lu-PSMA-617, uses a molecule that selectively seeks out and attaches to a specific protein on the cancer cell surface called PSMA (prostate-specific ...
FDA Approves Relugolix for Advanced Prostate Cancer
Jan 26, 2021 · A new drug approved by the Food and Drug Administration (FDA) is expected to immediately affect the treatment of some men with prostate cancer. In a large clinical trial, the drug, relugolix (Orgovyx), was shown to be more effective at reducing testosterone levels in men with advanced prostate cancer than another commonly used treatment ...
Talazoparib Combo Approved for Metastatic Prostate Cancer
Aug 4, 2023 · FDA based the approval of enzalutamide (Xtandi) plus talazoparib (Talzenna) on a large clinical trial that showed the combination was more effective than enzalutamide alone in treating men with metastatic castration-resistant prostate cancer.
New radiation therapy for prostate cancer reduces deaths ... - NBC News
Jun 3, 2021 · The trial was investigating a new, potentially groundbreaking type of treatment for prostate cancer, a therapy that specifically targets a protein on the cancer cells.